HealthStream Q2 2024 Adj EPS $0.16 Beats $0.12 Estimate, Sales $71.556M Miss $72.851M Estimate
Portfolio Pulse from Benzinga Newsdesk
HealthStream (NASDAQ:HSTM) reported Q2 2024 adjusted EPS of $0.16, beating the estimate of $0.12 by 33.33%. However, sales of $71.556 million missed the estimate of $72.851 million by 1.78%, though they increased by 3.41% year-over-year.
July 22, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthStream's Q2 2024 adjusted EPS of $0.16 beat estimates by 33.33%, but sales of $71.556 million missed estimates by 1.78%. Sales increased 3.41% year-over-year.
The significant beat on EPS is a positive indicator for profitability, which is likely to have a positive short-term impact on the stock price. The slight miss on sales is less impactful given the overall year-over-year growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100